Suchergebnisse - "Isaakidis, P."

Clinical utility of target-based next-generation sequencing for drug-resistant TB von Mansoor, H, Hirani, N, Chavan, V, Das, M, Sharma, J, Bharati, M, Oswal, V, Iyer, A, Morales, M, Joshi, A, Ferlazzo, G, Isaakidis, P, Ndlovu, Z, England, K

“… In high TB burden countries, access to drug susceptibility testing is a major bottleneck. Targeted next-generation sequencing (tNGS) is a promising technology …”
Weitere Angaben

Treatment outcomes for HIV and MDR-TB co-infected adults and children: systematic review and meta-analysis von Isaakidis, P, Casas, E C, Das, M, Tseretopoulou, X, Ntzani, E E, Ford, N

“… The incidence of multidrug-resistant tuberculosis (MDR-TB) is increasing in high human immunodeficiency virus (HIV) prevalence settings, with high associated …”
Weitere Angaben

Linezolid resistance in patients with drug-resistant TB von Vengurlekar, D, Walker, C, Mahajan, R, Dalal, A, Chavan, V, Galindo, M A, Iyer, A, Mansoor, H, Silsarma, A, Isaakidis, P, Spencer, H

Weitere Angaben

Adapting TB services during the COVID-19 pandemic in Mumbai, India von Meneguim, A C, Rebello, L, Das, M, Ravi, S, Mathur, T, Mankar, S, Kharate, S, Tipre, P, Oswal, V, Iyer, A, Mansoor, H, Kalon, S, Garone, D, Ferlazzo, G, Isaakidis, P

Weitere Angaben

Beyond 'cure' and 'treatment success': quality of life of patients with multidrug-resistant tuberculosis von Laxmeshwar, C, Stewart, A G, Dalal, A, Kumar, A M V, Kalaiselvi, S, Das, M, Gawde, N, Thi, S S, Isaakidis, P

“… Two drug-resistant tuberculosis (DR-TB) sites (MSF Clinic, Jupiter Hospital) in Mumbai, India. To assess health-related quality of life (HRQoL) and associated …”
Weitere Angaben

TB screening, prevention and treatment cascade in a Malawi prison von Mangochi, P, Bossard, C, Catacutan, C, Van Laeken, D, Kwitonda, C, Ortuno, R, Chiwaula, L, Meis, M, Abura, A, Furin, J, Mpunga, J, Goemare, E, Ellman, T, Garone, D, Ferlazzo, G, Isaakidis, P

“… BACKGROUND Incarcerated individuals, especially in high HIV and TB burden settings, are at increased risk of latent TB infection and/or TB disease. We …”
Weitere Angaben

New TB drugs for the treatment of children and adolescents with rifampicin-resistant TB in Mumbai, India von Das, M, Mamnoon, F, Mansoor, H, Meneguim, A C, Singh, P, Shah, I, Ravi, S, Kalon, S, Hossain, F N, Ferlazzo, G, Isaakidis, P, Furin, J, Acharya, S, Thakur, H P

“… Médecins Sans Frontières (MSF) clinic in Mumbai, India. To determine the final treatment outcomes, culture conversion and adverse events (AEs) during treatment …”
Weitere Angaben

Sustained treatment success at 12 months for drug-resistant TB patients on concomitant bedaquiline-delamanid von Chavan, V., Silsarma, A., Mahajan, R., Khan, S., Singh, P., Iyer, A., Dalal, A., Spencer, H., Isaakidis, P.

Volltext

Adverse events among people on delamanid for rifampicin-resistant tuberculosis in a high HIV prevalence setting von Hughes, J, Reuter, A, Chabalala, B, Isaakidis, P, Cox, H, Mohr, E

“… Patients with rifampicin-resistant tuberculosis (RR-TB) in the township of Khayelitsha, South Africa, were offered delamanid (DLM) within a decentralised RR-TB …”
Weitere Angaben

Clinical standards for drug-susceptible TB in children and adolescents von Chiang, S S, Graham, S M, Schaaf, H S, Marais, B J, Sant'Anna, C C, Sharma, S, Starke, J R, Triasih, R, Achar, J, Amanullah, F, Armitage, L Y, Aurilio, R B, Buck, W C, Centis, R, Chabala, C, Cruz, A T, Demers, A-M, du Preez, K, Enimil, A, Furin, J, Garcia-Prats, A J, Gonzalez, N E, Hoddinott, G, Isaakidis, P, Jaganath, D, Kabra, S K, Kampmann, B, Kay, A, Kitai, I, Lopez-Varela, E, Maleche-Obimbo, E, Malaspina, F Mestanza, Velásquez, J Niederbacher, Nuttall, J J C, Oliwa, J N, Andrade, I Orozco, Perez-Velez, C M, Rabie, H, Seddon, J A, Sekadde, M P, Shen, A, Skrahina, A, Soriano-Arandes, A, Steenhoff, A P, Tebruegge, M, Tovar, M A, Tsogt, B, van der Zalm, M M, Welch, H, Migliori, G B

“… These clinical standards aim to provide guidance for diagnosis, treatment, and management of drug-susceptible TB in children and adolescents. Fifty-two global …”
Weitere Angaben

Impact of the implementation of new guidelines on the management of patients with HIV infection at an advanced HIV clinic in Kinshasa, Democratic Republic of Congo (DRC) von Mangana, F., Massaquoi, L. D., Moudachirou, R., Harrison, R., Kaluangila, T., Mucinya, G., Ntabugi, N., Van Cutsem, G., Burton, R., Isaakidis, P.

“… Background HIV continues to be the main determinant morbidity with high mortality rates in Sub-Saharan Africa, with a high number of patients being late …”
Volltext

'I didn't know so many people cared about me': support for patients who interrupt drug-resistant TB treatment von Snyman, L, Venables, E, Trivino Duran, L, Mohr, E, Azevedo, V D, Harmans, X, Isaakidis, P

“… Early interventions for patients who interrupt their treatment for drug-resistant tuberculosis (DR-TB) are rarely reported and assessed. A novel, …”
Weitere Angaben

Re-inventing adherence: toward a patient-centered model of care for drug-resistant tuberculosis and HIV von O'Donnell, M R, Daftary, A, Frick, M, Hirsch-Moverman, Y, Amico, K R, Senthilingam, M, Wolf, A, Metcalfe, J Z, Isaakidis, P, Davis, J L, Zelnick, J R, Brust, J C M, Naidu, N, Garretson, M, Bangsberg, D R, Padayatchi, N, Friedland, G

“… Despite renewed focus on molecular tuberculosis (TB) diagnostics and new antimycobacterial agents, treatment outcomes for patients co-infected with …”
Weitere Angaben

'I'm fed up': experiences of prior anti-tuberculosis treatment in patients with drug-resistant tuberculosis and HIV von Furin, J, Isaakidis, P, Reid, A J, Kielmann, K

“… To understand the impact of past experiences of anti-tuberculosis treatment among patients co-infected with the human immunodeficiency virus and …”
Weitere Angaben

A positive COVID-19 test is associated with high mortality in RR-TB-HIV patients von Mohr-Holland, E, Daniels, J, Douglas-Jones, B, Mema, N, Scott, V, Trivino-Duran, L, Pfaff, C, Furin, J, Isaakidis, P

Weitere Angaben

Introduction of new drugs for drug-resistant TB in Iraq von Tesfahun, H, Moussally, K, Al-Ani, N Abdulkareem, Al-Salhi, L G, Kyi, H A, Simons, S, Isaakidis, P, Ferlazzo, G, Pangtey, H K, Mankhi, A A

Weitere Angaben

Evaluation of cluster randomized controlled trials in sub-Saharan Africa von Isaakidis, Petros, Ioannidis, John P A

“… Cluster randomized controlled trials (CRCTs) are attractive in settings in which individual randomization is difficult or impossible. This issue is common when …”
Weitere Angaben

Treatment of hypertension in rural Cambodia: results from a 6-year programme von Isaakidis, P, Raguenaud, M-E, Say, C, De Clerck, H, Khim, C, Pottier, R, Kuoch, S, Prahors, U, Chour, S, Van Damme, W, Reid, T

“… This study was aimed to describe the outcomes of a hypertension treatment programme in two outpatient clinics in Cambodia. We determined proportions of …”
Volltext

Relation between burden of disease and randomised evidence in sub-Saharan Africa: survey of research von Isaakidis, Petros, Swingler, George H, Pienaar, Elizabeth, Volmink, Jimmy, Ioannidis, John P A

“… Abstract Objective: To evaluate whether the amount of randomised clinical research on various medical conditions is related to the burden of disease and health …”
Volltext

Facteurs associés à la létalité chez les patients hospitalisés pour le VIH avancé von Abdourahimi, D, Yehadji, D, Briskin, E, Khine, E M, Arias, C, André, K S, Mukebela, F K, Ndayisenga, L, Isaakidis, P, Casas, E C, Steele, S J, Sacko, F B, omo, G

“… A unit supported by Médecins Sans Frontières (MSF) cares for patients with advanced HIV at Donka National Hospital, Conakry, Guinea.CONTEXTA unit supported by …”
Volltext